GSK to buy US cancer treatment firm Nuvalent for $10.6bn ⊖⊖
found
a story from The Guardian ⚠️ › International
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Nuvalent
since
auto-detected in 3 stories
Quick stats
Top stories today
15 hours ago
British drugmaker’s new chief executive Luke Miels announces one of its biggest deals
Business live – latest updates
GSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, a…
11 hours ago
Stocks making the biggest moves premarket: GSK, Nuvalent, J.M. Smucker, SailPoint and more ○
These are the stocks posting the largest moves in early trading.
18 hours ago
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT ⊖
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.